HSBC Holdings’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Other funds holding MDGL
BBA
HSBC Holdings's MDGL Position: Q3 2026 in Review
HSBC Holdings reduced its Madrigal Pharmaceuticals (MDGL) stake by 6.9% in Q3 2026, selling an estimated $743K and leaving 18,835 shares worth $9.5M. The position accounts for ﹤0.01% of the portfolio, ranked #996.
HSBC Holdings first reported a position in MDGL in Q1 2023 and has held it in 13 quarters since. The position peaked at $10.9M in Q2 2026. 442 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.
- HSBC Holdings held 18,835 shares of Madrigal Pharmaceuticals worth $9.5M as of Q3 2026.
- HSBC Holdings sold 1,405 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $743K.
- Madrigal Pharmaceuticals made up ﹤0.01% of HSBC Holdings's portfolio in Q3 2026, its #996 holding.
- HSBC Holdings first reported a position in Madrigal Pharmaceuticals in Q1 2023 and has held it in 13 quarters since.
- HSBC Holdings's Madrigal Pharmaceuticals position peaked at $10.9M in Q2 2026.
- 442 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.
Based on HSBC Holdings's 13F filing for Q3 2026, filed 16 Nov 2026.